Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to foundational, pre-competitive discovery technologies and services across six biologic modalities. Keyway™ TCR Discovery is Alloy’s integrated service offering developing protein engineering solutions for targeting pHLA complexes, spanning target selection through to final characterized leads of therapeutic TCR mimics and engineered TCRs.
LUMICKS is the world-leader in Dynamic Single-Molecule analysis (“DSM”) and is focused on establishing this breakthrough approach as a standard analytical method in molecular biology and drug discovery. We achieve this through the increasingly rapid adoption by scientific KOLs and publications by early adopters, as well as through our growing pharma customer base. With a complementary and growing product line, LUMICKS is well positioned to capitalize on the market opportunity for this technology across the academic and pharma segments.
Immudex is a life science company spearheading the global adoption of precision immune monitoring. We strive to provide researchers with reliable tools to monitor the cellular immune response. Our goal is to utilize the complex actions and interactions of the immune system to help researchers understand the causes, accelerate the diagnosis and more precisely predict the prognosis of diseases. Immudex markets Dextramer® and dCODE® (DNA-barcoded) MHC multimer technologies that grant researchers insights into disease-specific immunity resolved to antigen-specific cell populations and single cells
BioCopy provides high-throughput analyses for the development of immunotherapeutics and novel vaccines in the field of oncology and infectious diseases. At BioCopy, we are convinced that this holds the key to the medicine of the future.
We combine next generation microarrays with our highSCORE system and measure the binding kinetic of thousands of molecules fast and label-free – on one single chip in one measurement.
If you need to find out “which molecule binds best”, BioCopy is your perfect match! Our unique technology is based on the team’s wide- ranging expertise in biochemistry and microsystems engineering.
At BioCopy, we are defining new standards in our research and development. Work with us! Together, we can combine our technologies and expertise to develop the therapeutics of tomorrow.
2022 Media Partners
STEMCELL Science News
Looking to stay up to date on the latest cell biology research? Science News by STEMCELL Technologies can help. Our website and weekly newsletters keep scientists current with the latest peer-reviewed research, as well as industry and policy news.